SB-743921

SB-743921 · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB-743921, covering 2008-10-16 to 2016-10-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma [Phase 1, Phase 2]